InvestorsHub Logo
Followers 11
Posts 746
Boards Moderated 0
Alias Born 09/21/2017

Re: Dragon Lady post# 86173

Thursday, 12/21/2017 10:03:06 PM

Thursday, December 21, 2017 10:03:06 PM

Post# of 106834
I am fairly sure that USRM is the parent company of U.S. Stem Cell clinic, and I am also fairly sure that besides this, the American Stem Cell Center of Excellence in Dallas, while not being 100% owned by USRM, is one of their sources of revenue as well as one of the 287 clinics in their pipeline.

Correct me if I am wrong but if any company were to knowingly make fraudulent statements about their earnings, revenues, revenue streams, etc. wouldn’t they be shut down by the SEC? As well if these frauds were so easily found out wouldn’t there be some repercussions?


“As you know, U.S. Stem Cell, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. Since 1999, we believe that the Company has completed more clinical treatments (for both humans and animals) than any other regenerative company in the world. U.S. Stem Cell, Inc. is focused on the discovery, development and commercialization of cell-based therapies that prevent, treat or cure disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function. U.S. Stem Cell, Inc. is opening our own network of clinics AND has also partnered with other companies to build a national distribution network of affiliate clinics for stem cell therapies using the U.S. Stem Cell, Inc.-developed technologies—and one such group includes the American Stem Cell Centers of Excellence (“COE”) owned by General American Capital Partners. “ per USRM